诊断和治疗的挑战在素血管异常多中心的卡斯特曼病:一个病例报告
Chengbin Lu1, Xiaoli Ma2, Beibei Liu2
1The Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Peking University Cancer Hospital Yunnan, China.
The Journal of international medical research
|October 23, 2025
概括
异常多中心的卡斯特曼病可以通过组织病理学和炎症标志物进行诊断,当不能进行插白素-6检测时. 对于资源有限的患者来说,CHOP-thalidomide化疗是一种有效的治疗选择.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 病理学 病理学 病理学
背景情况:
- 异常多中心卡斯特曼病 (iMCD) 诊断通常依赖于介质素-6 (IL-6) 测试,在资源有限的地区,这种测试往往无法获得.
- 临床表现包括一般症状,如,发烧,疲劳和淋巴腺病,以及全身炎症标志物.
研究的目的:
- 介绍一个IMCD诊断和治疗在资源有限的环境中,没有IL-6测试的案例研究.
- 为了评估iMCD的替代治疗方案的疗效.
主要方法:
- 一名怀疑患有IMCD的女性患者接受了详细的临床评估,实验室检测系统性炎症和淋巴结活检.
- 组织病理学分析揭示了iMCD的特征性脉血管特征.
- 治疗包括循环胺,多克索鲁比辛,温克里斯和普雷迪尼松 (CHOP) 化学疗法与thalidomide相结合.
主要成果:
- 尽管没有IL-6水平,但通过组织病理学和炎症标志物确认了诊断.
- 患者实现了显著的淋巴结回归和炎症标志物的正常化.
- 在CHOP-thalidomide治疗方案的1年随访中观察到部分缓解.
结论:
- 严格的组织病理学和动态炎症标记可以在缺乏IL-6测试的环境中促进iMCD诊断.
- 在资源有限的地区,CHOP化疗和thalidomide的组合为iMCD提供了可行的和有效的治疗策略.
相关概念视频
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
805
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805
01:21Huntington Disease l: Introduction
110
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show...
110